SGLT2 inhibitors in the Perioperative period

Dr Jonathan Nicholson asks Dr Justin Burke how to safely navigate patients taking SGLT2 inhibitors through the perioperative period. Clinical dilemmas are discussed and practical guidance provided with discussion involving recent publications on detection, prevention and management of euglycaemic ketoacidosis.